Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Abdelkamel Chettab"'
Autor:
Morgane Denis, Abdelkamel Chettab, David Fahed, Alexandra Traverse-Glehen, Emeline Perrial, Lionel Karlin, Doriane Mathe, Charles Dumontet
Publikováno v:
Leukemialymphoma. 63(2)
Deleted in colorectal cancer (DCC) and uncoordinated-5 (UNC5) receptors, play a key role in tumor progression of several solid tumors by inducing apoptosis when unbound to their ligand netrin-1. Netrin 1 is currently being evaluated as a therapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2583498e0257c9ff78e2a4869ecce27
https://pubmed.ncbi.nlm.nih.gov/34585999
https://pubmed.ncbi.nlm.nih.gov/34585999
Autor:
Perrial Emeline, Charles Dumontet, Baulu Estelle, Matera Eva-Laure, Bousfiha Zineb, Fouret Julien, Lars Petter Jordheim, Abdelkamel Chettab
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
BCR pathway inhibitors idelalisib and ibrutinib were the first small molecule targeted agents for B-cell malignancies. In spite of encouraging response rates in various forms of B cell diseases, patients will eventually develop relapse due to the eme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f486a81b7988dde36db9d3314b4e0a1
https://doi.org/10.26502/jcsct.5079052
https://doi.org/10.26502/jcsct.5079052
Autor:
Abdelkamel Chettab, Ariel Savina, Juliette Sauveur, Eva Matera, Aurore Cleret, Charles Dumontet
Publikováno v:
Cancer Research. 76:309-309
Background: Overexpression of Human Epidermal growth factor Receptor 2 (HER2) in cancer was associated with poor outcome and high chances of recurrence before the development of anti-HER2 agents. Trastuzumab emtansine (T-DM1) is an antibody-drug conj
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff0381a79886011f2612d98aa8361dcb
https://doi.org/10.1158/1538-7445.am2016-309
https://doi.org/10.1158/1538-7445.am2016-309